Collectively, these results demonstrated that RG7388 functioned as a multifaceted anti-tumor agent against various TP53mutant NSCLC, exhibiting potent inhibition effects on proliferation and EGFR signaling pathways, as well as inductive effects on cell death. This evidence concerns the gene EGFR and non-small cell lung carcinoma.